Compare Stocks

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
ACRES Commercial Realty Corp. stock logo
ACR
ACRES Commercial Realty
$13.59
-2.7%
$12.29
$6.62
$14.35
$104.51M1.9930,287 shs17,662 shs
Accuride Co. stock logo
ACW
Accuride
$2.58
$0.00
$0.74
$2.84
N/AN/A350,178 shsN/A
Ceapro Inc. stock logo
CZO
Ceapro
C$0.24
-2.0%
C$0.23
C$0.15
C$0.64
C$18.79M1.3950,206 shs2,000 shs
AdvisorShares Q Portfolio Blended Allocation ETF stock logo
QPT
AdvisorShares Q Portfolio Blended Allocation ETF
$19.10
+0.1%
$19.10
$18.63
$27.54
$1.91MN/A1,912 shs19,400 shs
Silverback Therapeutics, Inc. stock logo
SBTX
Silverback Therapeutics
$8.50
+3.5%
$8.77
$2.80
$8.97
$306.49M0.6337,931 shs510,439 shs
Ten Starter Stocks For Beginners to Buy Now Cover

Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.

Get This Free Report

Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
ACRES Commercial Realty Corp. stock logo
ACR
ACRES Commercial Realty
+0.65%+2.05%+4.35%+45.50%+49.41%
Accuride Co. stock logo
ACW
Accuride
0.00%0.00%0.00%0.00%0.00%
Ceapro Inc. stock logo
CZO
Ceapro
0.00%0.00%0.00%+50.00%-57.89%
AdvisorShares Q Portfolio Blended Allocation ETF stock logo
QPT
AdvisorShares Q Portfolio Blended Allocation ETF
0.00%0.00%0.00%0.00%0.00%
Silverback Therapeutics, Inc. stock logo
SBTX
Silverback Therapeutics
0.00%-10.57%-5.09%+28.68%+25.73%

MarketRank™

CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
ACRES Commercial Realty Corp. stock logo
ACR
ACRES Commercial Realty
2.3921 of 5 stars
0.05.00.00.01.20.83.1
Accuride Co. stock logo
ACW
Accuride
N/AN/AN/AN/AN/AN/AN/AN/A
Ceapro Inc. stock logo
CZO
Ceapro
N/AN/AN/AN/AN/AN/AN/AN/A
AdvisorShares Q Portfolio Blended Allocation ETF stock logo
QPT
AdvisorShares Q Portfolio Blended Allocation ETF
N/AN/AN/AN/AN/AN/AN/AN/A
Silverback Therapeutics, Inc. stock logo
SBTX
Silverback Therapeutics
N/AN/AN/AN/AN/AN/AN/AN/A

Analyst Ratings

CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
ACRES Commercial Realty Corp. stock logo
ACR
ACRES Commercial Realty
N/AN/AN/AN/A
Accuride Co. stock logo
ACW
Accuride
N/AN/AN/AN/A
Ceapro Inc. stock logo
CZO
Ceapro
N/AN/AN/AN/A
AdvisorShares Q Portfolio Blended Allocation ETF stock logo
QPT
AdvisorShares Q Portfolio Blended Allocation ETF
0.00
N/AN/AN/A
Silverback Therapeutics, Inc. stock logo
SBTX
Silverback Therapeutics
N/AN/AN/AN/A

Sales & Book Value

CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
ACRES Commercial Realty Corp. stock logo
ACR
ACRES Commercial Realty
$91.13M1.15$5.35 per share2.54$52.77 per share0.26
Accuride Co. stock logo
ACW
Accuride
N/AN/AN/AN/AN/AN/A
Ceapro Inc. stock logo
CZO
Ceapro
C$11.30M1.66C$0.06 per share3.94C$0.38 per share0.63
AdvisorShares Q Portfolio Blended Allocation ETF stock logo
QPT
AdvisorShares Q Portfolio Blended Allocation ETF
N/AN/AN/AN/AN/AN/A
Silverback Therapeutics, Inc. stock logo
SBTX
Silverback Therapeutics
N/AN/AN/AN/A$7.41 per shareN/A

Profitability & Earnings

CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
ACRES Commercial Realty Corp. stock logo
ACR
ACRES Commercial Realty
$22.39M$0.3538.836.50N/A24.57%8.41%1.65%5/1/2024 (Confirmed)
Accuride Co. stock logo
ACW
Accuride
N/AN/A0.00N/AN/AN/AN/AN/A
Ceapro Inc. stock logo
CZO
Ceapro
-C$2.81M-C$0.03N/AN/A-24.86%-9.09%-6.91%5/23/2024 (Estimated)
AdvisorShares Q Portfolio Blended Allocation ETF stock logo
QPT
AdvisorShares Q Portfolio Blended Allocation ETF
N/AN/A0.00N/AN/AN/AN/AN/A
Silverback Therapeutics, Inc. stock logo
SBTX
Silverback Therapeutics
-$89.48M-$2.42N/AN/AN/A-29.62%-28.20%N/A

Latest SBTX, ACR, QPT, CZO, and ACW Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
5/1/2024N/A
ACRES Commercial Realty Corp. stock logo
ACR
ACRES Commercial Realty
$0.35N/A-$0.35N/AN/AN/A  

Dividends

CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
ACRES Commercial Realty Corp. stock logo
ACR
ACRES Commercial Realty
N/AN/AN/AN/AN/A
Accuride Co. stock logo
ACW
Accuride
N/AN/AN/AN/AN/A
Ceapro Inc. stock logo
CZO
Ceapro
N/AN/AN/AN/AN/A
AdvisorShares Q Portfolio Blended Allocation ETF stock logo
QPT
AdvisorShares Q Portfolio Blended Allocation ETF
$0.080.42%N/AN/AN/A
Silverback Therapeutics, Inc. stock logo
SBTX
Silverback Therapeutics
N/AN/AN/AN/AN/A

Debt

CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
ACRES Commercial Realty Corp. stock logo
ACR
ACRES Commercial Realty
3.76
84.01
84.01
Accuride Co. stock logo
ACW
Accuride
N/AN/AN/A
Ceapro Inc. stock logo
CZO
Ceapro
7.82
11.00
18.88
AdvisorShares Q Portfolio Blended Allocation ETF stock logo
QPT
AdvisorShares Q Portfolio Blended Allocation ETF
N/AN/AN/A
Silverback Therapeutics, Inc. stock logo
SBTX
Silverback Therapeutics
N/A
67.87
67.87

Ownership

Miscellaneous

CompanyEmployeesShares OutstandingFree FloatOptionable
ACRES Commercial Realty Corp. stock logo
ACR
ACRES Commercial Realty
2,0187.69 million7.46 millionOptionable
Accuride Co. stock logo
ACW
Accuride
N/AN/AN/ANot Optionable
Ceapro Inc. stock logo
CZO
Ceapro
N/A78.29 millionN/ANot Optionable
AdvisorShares Q Portfolio Blended Allocation ETF stock logo
QPT
AdvisorShares Q Portfolio Blended Allocation ETF
N/A100,000N/ANot Optionable
Silverback Therapeutics, Inc. stock logo
SBTX
Silverback Therapeutics
8336.06 million23.65 millionNot Optionable

SBTX, ACR, QPT, CZO, and ACW Headlines

SourceHeadline
Silverback Therapeutics (NASDAQ:SBTX) Trading Down 2%Silverback Therapeutics (NASDAQ:SBTX) Trading Down 2%
marketbeat.com - April 3 at 2:15 AM
ARS Pharmaceuticals Inc (SPRY)ARS Pharmaceuticals Inc (SPRY)
uk.investing.com - May 11 at 1:32 PM
Wild IslesWild Isles
wwf.org.uk - March 12 at 9:31 AM
A look back at RNA Therapeutics – day oneA look back at RNA Therapeutics – day one
pharmaphorum.com - February 24 at 12:35 AM
SPRY ARS Pharmaceuticals, Inc.SPRY ARS Pharmaceuticals, Inc.
seekingalpha.com - January 24 at 8:04 PM
ARS Pharma CEO Richard Lowenthal Holds 8% Silverback Stake After MergerARS Pharma CEO Richard Lowenthal Holds 8% Silverback Stake After Merger
247wallst.com - November 22 at 6:29 AM
Dr. Sarina Tanimoto Discloses Position in SBTX / Silverback TherapeuticsDr. Sarina Tanimoto Discloses Position in SBTX / Silverback Therapeutics
nasdaq.com - November 18 at 8:19 PM
ARS Pharmaceuticals Announces Presentation of Clinical Data Supporting neffy® (epinephrine nasal spray) for the Treatment of Allergic Reactions (Type I) including AnaphylaxisARS Pharmaceuticals Announces Presentation of Clinical Data Supporting neffy® (epinephrine nasal spray) for the Treatment of Allergic Reactions (Type I) including Anaphylaxis
finance.yahoo.com - November 10 at 6:41 PM
ARS Pharmaceuticals Closes Merger with Silverback TherapeuticsARS Pharmaceuticals Closes Merger with Silverback Therapeutics
finance.yahoo.com - November 8 at 5:59 PM
Silverback : FDA Accepts ARS Pharms NDA For Neffy For Treatment Of Allergic ReactionsSilverback : FDA Accepts ARS Pharm's NDA For Neffy For Treatment Of Allergic Reactions
markets.businessinsider.com - October 28 at 8:15 AM
FDA accepts ARS Pharma’s NDA for NeffyFDA accepts ARS Pharma’s NDA for Neffy
thepharmaletter.com - October 24 at 10:29 AM
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates HIL, SBTX, COWN, AERISHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates HIL, SBTX, COWN, AERI
kentuckytoday.com - October 23 at 7:22 PM
Silverback Therapeutics, Inc. announces the FDA’s acceptance of ARS Pharmaceuticals’ NDA for neffy® (epinephrine nasal spray) for the Treatment of Allergic Reactions (type I) including AnaphylaxisSilverback Therapeutics, Inc. announces the FDA’s acceptance of ARS Pharmaceuticals’ NDA for neffy® (epinephrine nasal spray) for the Treatment of Allergic Reactions (type I) including Anaphylaxis
finance.yahoo.com - October 21 at 7:59 AM
Is Silverback Therapeutics Inc (SBTX) Stock a Good Investment?Is Silverback Therapeutics Inc (SBTX) Stock a Good Investment?
aaii.com - October 19 at 11:52 AM
SHAREHOLDER ALERT: The M&A Class Action Firm is Investigating the Merger – RFP, SBTX, AAWW, COWNSHAREHOLDER ALERT: The M&A Class Action Firm is Investigating the Merger – RFP, SBTX, AAWW, COWN
bakersfield.com - October 12 at 11:07 PM
INVESTIGATION ALERT: Halper Sadeh LLC Investigates CVET, SBTX, IRBTINVESTIGATION ALERT: Halper Sadeh LLC Investigates CVET, SBTX, IRBT
markets.businessinsider.com - September 17 at 5:10 AM
SBTX Silverback Therapeutics, Inc.SBTX Silverback Therapeutics, Inc.
seekingalpha.com - September 15 at 10:58 PM
SHAREHOLDER NOTICE: Halper Sadeh LLP Investigates FTAI, SBTX, CVET, GBTSHAREHOLDER NOTICE: Halper Sadeh LLP Investigates FTAI, SBTX, CVET, GBT
markets.businessinsider.com - September 6 at 11:53 AM
SHAREHOLDER INVESTIGATION NOTICE: Halper Sadeh LLP Investigates HNGR, SBTX, IEA, ZYSHAREHOLDER INVESTIGATION NOTICE: Halper Sadeh LLP Investigates HNGR, SBTX, IEA, ZY
markets.businessinsider.com - August 23 at 6:32 PM
SHAREHOLDER INVESTIGATION NOTICE: Halper Sadeh LLP Investigates VIVO, HNGR, SBTXSHAREHOLDER INVESTIGATION NOTICE: Halper Sadeh LLP Investigates VIVO, HNGR, SBTX
apnews.com - August 17 at 12:02 PM
SHAREHOLDER INVESTIGATION NOTICE: Halper Sadeh LLP Investigates IEA, BBQ, SBTXSHAREHOLDER INVESTIGATION NOTICE: Halper Sadeh LLP Investigates IEA, BBQ, SBTX
apnews.com - August 11 at 1:33 AM
SHAREHOLDER ALERT: Weiss Law Reminds SBTX, LJPC, CNVY, and DRE Shareholders About Its Ongoing InvestigationsSHAREHOLDER ALERT: Weiss Law Reminds SBTX, LJPC, CNVY, and DRE Shareholders About Its Ongoing Investigations
morningstar.com - July 30 at 7:00 AM
INVESTIGATION ALERT: Halper Sadeh LLP Investigates HNGR, SBTX, IEA, ZYINVESTIGATION ALERT: Halper Sadeh LLP Investigates HNGR, SBTX, IEA, ZY
apnews.com - July 28 at 2:21 AM
Shareholder Alert - The M&A Class Action Firm Announces the Investigation of Silverback Therapeutics, Inc. - SBTXShareholder Alert - The M&A Class Action Firm Announces the Investigation of Silverback Therapeutics, Inc. - SBTX
benzinga.com - July 27 at 9:21 PM

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

All Headlines

Company Descriptions

ACRES Commercial Realty logo

ACRES Commercial Realty

NYSE:ACR
ACRES Commercial Realty Corp., a real estate investment trust (REIT), focuses on the origination, holding, and management of commercial real estate mortgage loans and equity investments in commercial real estate property in the United States. It invests in commercial real estate-related assets, including floating-rate first mortgage loans, first priority interests in first mortgage loans, subordinated interests in first mortgage loans, mezzanine financing, preferred equity investments, and commercial mortgage-backed securities. The company qualifies as a real estate investment trust for federal income tax purposes. It generally would not be subject to federal corporate income taxes if it distributes at least 90% of its taxable income to its stockholders. The company was formerly known as Exantas Capital Corp. and changed its name to ACRES Commercial Realty Corp. in February 2021. ACRES Commercial Realty Corp. was incorporated in 2005 and is based in Uniondale, New York.
Accuride logo

Accuride

NYSE:ACW
Accuride Corporation is a United States-based manufacturer and supplier of wheels, wheel-end components and other products to the North American commercial vehicle industry. The Company's products include steel and aluminum commercial vehicle wheels and assemblies, truck body and chassis parts, and gray, ductile and austempered ductile iron castings. The Company's products are marketed under various brands, such as Accuride Wheel End Solutions (Accuride Wheels and Gunite), Accu-Flange and Gianetti Ruote. The Company uses Steel Armor steel wheel powder coating technology. The Company also offers stud-piloted, tubeless and tube-type forged aluminum wheels, brake drums and disc wheel hubs in commercial vehicles. The Company serves the original equipment manufacturers (OEMs) and their related aftermarket channels. The Company serves the commercial vehicle market, including heavy and medium-duty trucks, commercial trailers, light trucks, buses, and specialty and military vehicles.
Ceapro logo

Ceapro

CVE:CZO
Ceapro Inc., a biotechnology company, engages in the development and marketing of health and wellness products and technology relating to plant extracts in the United States, Germany, China, Canada, and internationally. The company is involved in the development of proprietary extraction technologies and the application of these technologies to the production, development, and commercialization of active ingredients, such as oat beta glucan and avenanthramides, which are derived from oats and other renewable plant resources for healthcare and cosmetic industries. It also offers natural active ingredients, including oat powder, oat oil, oat peptides, and lupin peptides to the personal care, cosmetic, medical, and animal health industries; anti-aging skincare products to the cosmeceutical industries; and veterinary therapeutic products, including an oat shampoo, an ear cleanser, and a dermal complex/conditioner. The company has a research collaboration with the Angiogenesis Foundation. The company was incorporated in 1997 and is headquartered in Edmonton, Canada.
AdvisorShares Q Portfolio Blended Allocation ETF logo

AdvisorShares Q Portfolio Blended Allocation ETF

NYSEARCA:QPT
Silverback Therapeutics logo

Silverback Therapeutics

NASDAQ:SBTX
Silverback Therapeutics, Inc., a biopharmaceutical company, develops tissue-targeted therapeutics for the treatment of chronic viral infections, cancer, and other serious diseases. The company offers SBT8230 to treat chronic hepatitis B virus infection by eliciting an anti-viral immune response by targeting TLR8 activation to the liver. Silverback Therapeutics, Inc. was incorporated in 2016 and is headquartered in Seattle, Washington.